CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum

CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum

Background. According to recent studies, amyloid-β (Aβ) isoforms as cerebrospinal fluid (CSF) biomarkers have remarkable predictive value for cognitive decline in the early stages of Alzheimer’s disease (AD). Herein, we aimed to investigate the correlations between several targeted proteomics in CSF...

Full description

Bibliographic Details
Main Authors: Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, Linda Baidoo, Ali Rezaei, Shima Karbasi, Mohammad Sadeghi, Mahan Shafie, Mahsa Mayeli, null Alzheimer’s Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:International Journal of Alzheimer's Disease
Online Access:http://dx.doi.org/10.1155/2023/5336273

Internet

http://dx.doi.org/10.1155/2023/5336273

Similar Items